System and method for evaluating the cost-effectiveness of providing growth hormone replacement therapy
OwnerJonathan Jones, Adrian Griffininventors
Life of this patent
Estimating the term…
Abstract
Systems and methods of determining a plurality of cost/utility estimates are used to evaluate the cost effectiveness of providing growth hormone replacement therapy to individuals having growth hormone deficiency. In an exemplary embodiment of the invention, the system has executable instructions for predicting the development of one or more morbidities in an individual having growth hormone deficiency over a simulated life cycle; and for determining and outputting a plurality of cost/utility estimates which may be used by a researcher to evaluate the cost-effectiveness of providing growth hormone replacement therapy.
Claims20
A method of determining a plurality of cost/utility estimates for evaluating the cost effectiveness of providing growth hormone replacement therapy to an individual having growth hormone deficiency, the method comprising the steps of:
- a) identifying one or more morbidities associated with growth hormone deficiency;
- b) predicting the development of the one or more morbidities in an individual being treated with growth hormone replacement therapy over a simulated life cycle;
- c) estimating a cost associated with providing growth hormone replacement therapy and with treating the predicted developed one or more morbidities in the individual being treated with growth hormone replacement therapy over the simulated life cycle;
- d) estimating a utility associated with being treated with growth hormone replacement therapy;
- e) predicting the development of the one or more morbidities in an individual not being treated with growth hormone replacement therapy over a simulated life cycle;
- f) estimating a cost associated with treating the predicted developed one or more morbidities in the individual not being treated with growth hormone replacement therapy over the simulated life cycle;
- and
- g) estimating a utility with not being treated with growth hormone replacement therapy.
A computer-readable medium containing instructions for outputting a plurality of cost/utility estimates for evaluating the cost effectiveness of providing growth hormone replacement therapy to an individual having growth hormone deficiency;
- the instructions being operable to:
- a) predict the development of one or more predetermined morbidities in an individual being treated with growth hormone replacement therapy over a simulated life cycle;
- b) estimate a cost associated with providing growth hormone replacement therapy and with treating the predicted developed one or more morbidities in the individual being treated with growth hormone replacement therapy over the simulated life cycle;
- c) estimate a utility associated with being treated with growth hormone replacement therapy;
- d) predict the development of the one or more predetermined morbidities in an individual not being treated with growth hormone replacement therapy over a simulated life cycle;
- e) estimate a cost associated with treating the predicted developed one or more morbidities in the individual not being treated with growth hormone replacement therapy over the simulated life cycle;
- f) estimate a utility associated with not being treated with growth hormone replacement therapy;
- and
- g) output the estimated cost and estimated utility associated with the individual being treated with growth hormone replacement therapy and the estimated cost and estimated utility associated with the individual not being treated with growth hormone replacement therapy.
A system for outputting a plurality of cost/utility estimates for determining the cost effectiveness of providing growth hormone replacement therapy to an individual having growth hormone deficiency, the system comprising:
- a database comprising:
- data identifying one or more morbidities associated with growth hormone deficiency;
- data identifying a probability of developing the one or more morbidities;
- data identifying a cost associated with treating the one or more morbidities;
- data identifying a cost associated with providing growth hormone treatment therapy;
- data identifying a utility associated with receiving growth hormone treatment therapy;
- and
- data identifying a utility associated with not receiving growth hormone treatment therapy;
- and
- a computer system comprising executable instructions in communication with the database and configured to predict the development of one or more morbidities over a simulated life cycle, and further comprising executable instructions configured to output a plurality of cost/utility estimates based on the data.
Dependencies are inferred from the claim text.